892 related articles for article (PubMed ID: 28954042)
21. Diagnosis and Treatment of Gastroesophageal Reflux in Infants and Children.
Baird DC; Harker DJ; Karmes AS
Am Fam Physician; 2015 Oct; 92(8):705-14. PubMed ID: 26554410
[TBL] [Abstract][Full Text] [Related]
22. Characteristics of children and adolescents first prescribed proton pump inhibitors or histamine-2-receptor antagonists: an observational cohort study.
Ruigómez A; Kool-Houweling LMA; García Rodríguez LA; Penning-van Beest FJA; Herings RMC
Curr Med Res Opin; 2017 Dec; 33(12):2251-2259. PubMed ID: 28562108
[TBL] [Abstract][Full Text] [Related]
23. [Gastroesophageal reflux treatment: from therapeutic abstention to surgery].
Tounian P
Arch Pediatr; 2009 Oct; 16(10):1424-8. PubMed ID: 19632098
[TBL] [Abstract][Full Text] [Related]
24. Low-dose or standard-dose proton pump inhibitors for maintenance therapy of gastro-oesophageal reflux disease: a cost-effectiveness analysis.
You JH; Lee AC; Wong SC; Chan FK
Aliment Pharmacol Ther; 2003 Mar; 17(6):785-92. PubMed ID: 12641500
[TBL] [Abstract][Full Text] [Related]
25. Prospective Study of Gastroesophageal Reflux, Use of Proton Pump Inhibitors and H2-Receptor Antagonists, and Risk of Hearing Loss.
Lin BM; Curhan SG; Wang M; Jacobson BC; Eavey R; Stankovic KM; Curhan GC
Ear Hear; 2017; 38(1):21-27. PubMed ID: 27556519
[TBL] [Abstract][Full Text] [Related]
26. Short-term treatment of gastroesophageal reflux disease.
van Pinxteren B; Numans ME; Lau J; de Wit NJ; Hungin AP; Bonis PA
J Gen Intern Med; 2003 Sep; 18(9):755-63. PubMed ID: 12950485
[TBL] [Abstract][Full Text] [Related]
27. A review of medical therapy for proton pump inhibitor nonresponsive gastroesophageal reflux disease.
Hillman L; Yadlapati R; Thuluvath AJ; Berendsen MA; Pandolfino JE
Dis Esophagus; 2017 Sep; 30(9):1-15. PubMed ID: 28859358
[TBL] [Abstract][Full Text] [Related]
28. Medical treatment of gastro-oesophageal reflux disease.
De Giorgi F; Savarese MF; Atteo E; Leone CA; Cuomo R
Acta Otorhinolaryngol Ital; 2006 Oct; 26(5):276-80. PubMed ID: 17345932
[TBL] [Abstract][Full Text] [Related]
29. Use of anti-reflux medications in infants under 1 year of age: a retrospective drug utilization study using national prescription reimbursement data.
O'Reilly D; Conway R; O'Connor L; Fitzpatrick P
Eur J Pediatr; 2020 Dec; 179(12):1963-1967. PubMed ID: 33051717
[TBL] [Abstract][Full Text] [Related]
30. Concomitant Administration of a Histamine2 Receptor Antagonist and Proton Pump Inhibitor Enhances Gastric Acid Suppression.
Abdul-Hussein M; Freeman J; Castell D
Pharmacotherapy; 2015 Dec; 35(12):1124-9. PubMed ID: 26621819
[TBL] [Abstract][Full Text] [Related]
31. Intravenous proton-pump inhibitors versus H2-antagonists for treatment of GI bleeding.
Huggins RM; Scates AC; Latour JK
Ann Pharmacother; 2003 Mar; 37(3):433-7. PubMed ID: 12639176
[TBL] [Abstract][Full Text] [Related]
32. Dyspepsia and reflux in primary care: rough DIAMOND of a trial.
van Zanten SV
Lancet; 2009 Jan; 373(9659):187-8. PubMed ID: 19150689
[No Abstract] [Full Text] [Related]
33. Limited efficacy of antigastroesophageal reflux medications in children.
Berman J
J Pediatr; 2015 May; 166(5):1321-2. PubMed ID: 25919740
[No Abstract] [Full Text] [Related]
34. Efficacy and safety of traditional Chinese herbal formula combined with western medicine for gastroesophageal reflux disease: A protocol for systematic review and meta-analysis.
Lin W; Huang G; Liu X; Lin H; Zhou H; Feng C; Wang T; Liang R
Medicine (Baltimore); 2020 Oct; 99(41):e22454. PubMed ID: 33031277
[TBL] [Abstract][Full Text] [Related]
35. [Gastroesophageal Reflux Disease].
Park CH; Lee SK
Korean J Gastroenterol; 2019 Feb; 73(2):70-76. PubMed ID: 30845382
[TBL] [Abstract][Full Text] [Related]
36. Safety of medication options for treating pediatric esophagitis.
Bardou M; Fortinsky KJ
Expert Opin Drug Saf; 2015 Jul; 14(7):1087-96. PubMed ID: 25913014
[TBL] [Abstract][Full Text] [Related]
37. [Gastroesophageal reflux disease: pathogenetic basis of differentiated tactics of treatment].
Tkachenko EI; Uspenskiĭ IuP; Karateev AE; Bakulin IG; Pakhomova IG
Eksp Klin Gastroenterol; 2009; (2):104-14. PubMed ID: 19552028
[TBL] [Abstract][Full Text] [Related]
38. [Gastroesophageal reflux disease: an overview].
Nasi A; de Moraes-Filho JP; Cecconello I
Arq Gastroenterol; 2006; 43(4):334-41. PubMed ID: 17406765
[TBL] [Abstract][Full Text] [Related]
39. Treatment of gastroesophageal reflux disease.
Guimarães EV; Marguet C; Camargos PA
J Pediatr (Rio J); 2006 Nov; 82(5 Suppl):S133-45. PubMed ID: 17136289
[TBL] [Abstract][Full Text] [Related]
40. Healthcare costs of GERD and acid-related conditions in pediatric patients, with comparison between histamine-2 receptor antagonists and proton pump inhibitors.
Kothari S; Nelson SP; Wu EQ; Beaulieu N; McHale JM; Dabbous OH
Curr Med Res Opin; 2009 Nov; 25(11):2703-9. PubMed ID: 19775195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
